Survival analysis of target drugs and other oral drugs in patients with advanced non-small cell lung cancer
碩士 === 國立中央大學 === 工業管理研究所 === 105 === In recent years, the proportion of target drugs used to treat advanced non-small cell lung cancer has increased. In Taiwan, the common target drug is Erlotinib (Tarceva®) and Gefitinib (Iressa®). The success of target therapy drugs brings the treatment of lung c...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2017
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/yp9uq7 |